Tag Archives: Jeffrey M. Friedman
The award, given by the American Society for Clinical Investigation and the Harrington Discovery Institute, honors those who advance science with achievements notable for innovation, creativity, and potential for clinical application. Friedman is being recognized for his discovery of leptin. More »
Feeling hungry or full leads us to change how much we eat, but the molecular wiring of this process is not well understood. Scientists have identified a new player in this circuit called amylin, which works together with the hormone leptin to reduce food consumption. More »
The Kavli Foundation and The Rockefeller University today announced the formation of the Kavli Neural Systems Institute (Kavli NSI) at Rockefeller, funded by a $20 million endowment supported equally by Kavli and Rockefeller. The Institute will become part of a network of seven Kavli Institutes carrying out fundamental research in neuroscience, and a broader network of 20 Kavli Institutes dedicated to astrophysics, nanoscience, neuroscience, and theoretical physics. More »
Rockefeller University scientists Jeffrey M. Friedman and Leslie B. Vosshall have been awarded the distinction of AAAS Fellow. Election as a fellow is an honor bestowed upon AAAS members by their peers. More »
A team is developing a system that would make it possible to remotely control biological targets in living animals — rapidly, without wires, implants or drugs. During a test, they used radio waves or a magnetic field to turn on insulin production in mice. More »
The good news and the bad news about beating obesity “We don’t ‘pillory people for being very tall or short,’ [Jeffrey] Friedman said, so it makes no sense to blame obese people for being that way–or for obese people … More »
A new technique allows researchers to examine gene expression in neurons that send messages to a synapse. A test run examined dopamine neurons that project to the brain region known as the nucleus accumbens.
Tessier-Lavigne, Rockefeller president and head of the Laboratory of Brain Development, and Jeffrey M. Friedman head of the Laboratory of Molecular Genetics, were elected to the honorary society and independent policy research center along with 198 other leaders in science, art, academia and the civic, corporate and philanthropic arenas. The current membership includes some 250 Nobel laureates and more than 60 Pulitzer Prize winners, and 23 other Rockefeller University faculty members are fellows.
Friedman is being recognized for his groundbreaking discovery of leptin, a hormone that regulates food intake and energy expenditure. His observations provided scientists with a new target for treating obesity and other metabolic diseases.
This year’s Albert Lasker Award for Basic Medical Research, the most prestigious American prize in science, honors Rockefeller University’s Jeffrey M. Friedman, who discovered leptin, a hormone that regulates food intake and body weight. More »
Jeffery Friedman shares the 14th Keio Medical Science Prize, awarded annually to researchers for outstanding achievements in the fields of life sciences and medicine, for the “discovery of leptin and the study of its physiological functions.” More »
Jeffrey Friedman, Marilyn M. Simpson Professor and head of the Laboratory of Molecular Genetics at Rockefeller, received the 2009 Shaw Prize in Life Science and Medicine. He shares the $1 million award, known as the Nobel Prize of the East, with the Jackson Laboratory’s Douglas L. Coleman for their work leading to the discovery of leptin, a hormone that regulates food intake and body weight. More »
By using a mouse that lacks fat cells and observing the growth of fat after injections of different kinds of immature cells, Rockefeller University scientists have discovered an important fat precursor cell that may in time explain how changes in the numbers of fat cells might increase and lead to obesity. The scientists’ finding could also have implications for understanding how fat cells affect conditions such as diabetes and cardiovascular disease. More »
The sixth Danone Institute International Prize for Nutrition, an award that honors innovative nutritional research, was given to Rockefeller University’s Jeffrey Friedman today at the European Nutrition Conference in Paris. More »
The National Academy of Sciences announced today that Rockefeller University scientist Jeffrey M. Friedman will receive the National Academy of Sciences’ Jessie Stevenson Kovalenko Medal — a medal and prize of $25,000 awarded every three years for important contributions to the medical sciences. More »
With fewer than 4,000 residents, the genetically isolated Micronesian island of Kosrae, in the West Pacific, provides an ideal population in which to research heritability of disease. Now this data is beginning to yield intriguing results about the genetic basis of complex disease. More »
Rockefeller University’s Jeffrey M. Friedman, a molecular geneticist whose discovery of the hormone leptin and its role in regulating body weight has changed our understanding of the causes of human obesity, was elected to the Institute of Medicine of the National Academies, it was announced today. More »
Rockefeller University’s Jeffrey M. Friedman, M.D., Ph.D., a molecular geneticist whose discovery of the hormone leptin and its role in regulating body weight has changed our understanding of the causes of human obesity, has received two prestigious awards for this work: the Gairdner Foundation International Award and the Passano Foundation Award. More »
Through population screening on the island of Kosrae, Rockefeller scientists discover a mutant gene that controls dietary cholesterol absorption
Using DNA from 1,000 inhabitants of the Micronesian island of Kosrae, Rockefeller University scientists have discovered a mutant gene that affects an individual’s absorption of dietary cholesterol. The findings are reported in the Journal of Lipid Research. The researchers hope their discovery will help tease apart the tangle of genes that control cholesterol absorption, one of the factors that contributes to high blood cholesterol levels, which are a major risk factor for heart attacks. More »